Malcolm Brenner's most recent trade in Kalaris Therapeutics Inc. was a trade of 35,000 Common Stock done . Disclosure was reported to the exchange on June 6, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 100,197 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 35,000 | 65,197 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 25 May 2021 | 818,663 | 0 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 30.39 per share. | 04 Mar 2021 | 23,660 | 843,094 | - | 30.4 | 719,034 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 34.67 per share. | 04 Mar 2021 | 15,961 | 900,391 | - | 34.7 | 553,314 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 31.27 per share. | 04 Mar 2021 | 15,289 | 827,805 | - | 31.3 | 478,075 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 35.46 per share. | 04 Mar 2021 | 13,876 | 886,515 | - | 35.5 | 492,025 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 37.41 per share. | 04 Mar 2021 | 10,947 | 866,754 | - | 37.4 | 409,555 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 36.58 per share. | 04 Mar 2021 | 8,814 | 877,701 | - | 36.6 | 322,405 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 32.19 per share. | 04 Mar 2021 | 6,141 | 821,664 | - | 32.2 | 197,670 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 33.31 per share. | 04 Mar 2021 | 2,300 | 819,364 | - | 33.3 | 76,604 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 34.40 per share. | 04 Mar 2021 | 701 | 818,663 | - | 34.4 | 24,117 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 38.39 per share. | 01 Mar 2021 | 12,825 | 955,794 | - | 38.4 | 492,327 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 39.00 per share. | 01 Mar 2021 | 8,869 | 946,925 | - | 39.0 | 345,900 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 38.53 per share. | 01 Mar 2021 | 8,500 | 916,352 | - | 38.5 | 327,472 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 38.27 per share. | 01 Mar 2021 | 7,317 | 935,881 | - | 38.3 | 280,016 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 37.73 per share. | 01 Mar 2021 | 6,032 | 924,852 | - | 37.7 | 227,617 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 37.35 per share. | 01 Mar 2021 | 3,727 | 943,198 | - | 37.3 | 139,199 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 36.91 per share. | 01 Mar 2021 | 3,383 | 930,884 | - | 36.9 | 124,861 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 39.14 per share. | 01 Mar 2021 | 1,614 | 934,267 | - | 39.1 | 63,173 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 41.78 per share. | 19 Feb 2021 | 11,990 | 988,531 | - | 41.8 | 500,935 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 42.80 per share. | 19 Feb 2021 | 8,779 | 977,418 | - | 42.8 | 375,746 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 39.46 per share. | 19 Feb 2021 | 3,688 | 970,620 | - | 39.5 | 145,529 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 38.75 per share. | 19 Feb 2021 | 2,800 | 974,308 | - | 38.7 | 108,499 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 41.58 per share. | 19 Feb 2021 | 2,334 | 986,197 | - | 41.6 | 97,054 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 19 Feb 2021 | 1,801 | 968,819 | - | 40.4 | 72,769 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 43.37 per share. | 19 Feb 2021 | 310 | 977,108 | - | 43.4 | 13,446 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 41.19 per share. | 19 Feb 2021 | 200 | 968,619 | - | 41.2 | 8,238 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 41.49 per share. | 18 Feb 2021 | 2,982 | 1,000,521 | - | 41.5 | 123,732 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 40.34 per share. | 18 Feb 2021 | 2,800 | 1,003,503 | - | 40.3 | 112,950 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 39.68 per share. | 18 Feb 2021 | 975 | 1,006,303 | - | 39.7 | 38,684 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 41.75 per share. | 16 Feb 2021 | 5,120 | 1,013,543 | - | 41.8 | 213,769 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 41.29 per share. | 16 Feb 2021 | 2,765 | 1,007,478 | - | 41.3 | 114,169 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 38.66 per share. | 16 Feb 2021 | 1,200 | 1,011,243 | - | 38.7 | 46,393 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 39.97 per share. | 16 Feb 2021 | 1,000 | 1,010,243 | - | 40.0 | 39,966 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 42.25 per share. | 16 Feb 2021 | 1,000 | 1,012,543 | - | 42.3 | 42,250 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 41.99 per share. | 16 Feb 2021 | 200 | 1,007,278 | - | 42.0 | 8,398 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Sale of securities on an exchange or to another person at price $ 43.13 per share. | 16 Feb 2021 | 100 | 1,012,443 | - | 43.1 | 4,313 | Common Stock |
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | 03 Aug 2020 | 1,518,018 | 0 | - | - | Series A-3 Convertible Preferred Stock | ||
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | 03 Aug 2020 | 1,018,663 | 1,018,663 | - | - | Common Stock | ||
| Kalaris Therapeutics Inc. | Malcolm Brenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) |